BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 15736006)

  • 1. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
    Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM; Sheen IS; Liaw YF
    Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the correlation between titer of antibodies against different function regions of hepatitis C virus and HCV RNA of chronic patients].
    Zhang HQ; Wang GH; Chen K; Xiu BS; Song XG; Liu HZ; Ling SG
    Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):754-5. PubMed ID: 14697143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
    Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
    Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.
    Moreno M; Pérez-Alvarez R; Rodrigo L; Pérez-López R; Suárez-Leiva P
    J Viral Hepat; 2006 Jan; 13(1):28-33. PubMed ID: 16364079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic relevance of F protein in chronic hepatitis C virus infection.
    Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
    Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serologic response against hepatitis C virus as a predictive factor to the treatment with interferon].
    Garrido A; Lepe JA; Guerrero FJ; Palomo S
    Enferm Infecc Microbiol Clin; 2000 Dec; 18(10):512-5. PubMed ID: 11198002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV].
    Fedorchenko SV; Martynovich TL; Liashok OV; Kariuk ZhA; Ianchenko VI
    Ter Arkh; 2010; 82(3):52-6. PubMed ID: 20564924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third-generation assays for hepatitis C antibodies: a four-year study of pattern changes in patients with chronic and past infection.
    Perniola R; De Rinaldis C; Leo G
    Panminerva Med; 1999 Dec; 41(4):291-4. PubMed ID: 10705708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study.
    Kee KM; Wang JH; Hung CH; Chen CH; Lee CM; Chang KC; Tseng PL; Yen YH; Lin CY; Lu SN
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1106-11. PubMed ID: 22004331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological studies of anti-HCV P1P4 core antibody].
    Shibuya A; Asano A; Tsuchihashi T; Sakurai K; Takeuchi A; Shibata H
    Rinsho Byori; 1995 Mar; 43(3):285-9. PubMed ID: 7538180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to hepatitis C virus infection after liver transplantation.
    Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
    Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.